Company intelligence
MINAKEM
Your Specialist Partner for API Development and Manufacturing
About MINAKEM
MINAKEM is a fully integrated development partner and commercial manufacturer for pharmaceutical companies. - API manufacturing (Innovators/Generics and Highly Potent) - Custom development (process development and optimization) - Custom manufacturing - Production of Key intermediates and building blocks All development and manufacturing activities are supported by highly skilled R&D technical centres, strong and state of the art analytical services including solid form and QBD laboratories. MINAKEM’s talented team also ensures high-quality services in Quality Assurance, Regulatory Affairs, Safety, Health and Environment (SHE). Minakem is a technology-driven company with expertise in complex multi-step synthesis, pressure chemistry, chiral synthesis, halogenation chemistry, steroid chemistry and “prazole” chemistry… Minakem has operations in 3 different sites, which are all US FDA and local health agencies approved and is : - Dunkirk, France – former AstraZeneca “prazoles” and budesonide production site - Beuvry-la-Forêt, France - Louvain-la-Neuve, Belgium – former Ajimonoto-Omnichem site, specialized in vinca alkaloids synthesis - Montréal , Canada - former Delmar site Strong synergies within MINAKEM facilities sites offer customers the flexibility, responsiveness and cost-effectiveness paired with the strong technical know-how to create significant added value within our customers’ supply chains. Minakem is part of the Minafin Group (link to Minafin site), and as such has access to all technologies, resources, and capabilities to respond to its client’s needs, especially with Leuna, Germany, and Pennakem (USA).
Verified activity
Signals from MINAKEM
5 published signals
Presence & Recognition
MINAKEM is attending CPHI Milan from October 6 to 8, bringing its API expertise to the pharma industry's biggest stages.
Reported by MINAKEM
Presence & Recognition
MINAKEM is exhibiting at CPHI Milan 2026 at Booth #6A74
Reported by Alen Bozicevic
Legal & Regulatory
MINAKEM has officially validated its climate targets by the Science Based Targets initiative (SBTi)
Reported by MINAKEM
Legal & Regulatory
MINAKEM has validated its climate targets by the Science Based Targets initiative.
Reported by Olivier Ubrich
Legal & Regulatory
MINAKEM achieved SBTi validation, reflecting its commitment to aligning with the internationally recognized framework adopted by leading companies across the pharmaceutical and CDMO industry.
Reported by Alen Bozicevic